Decentralized Clinical Trials: Finding The Right Balance Between Automation And Human Touch

Despite some clinical trials returning to in-person setups, Clinical Trials Arena recently reported that in 2022, more than 1,200 studies featured a decentralized or virtual component—a 28% increase from a year earlier. While the research suggests that decentralization is here to stay, the lack of human oversight can present potentially serious risks.

Although remote data collection technologies via smart phone apps and wearable devices can make it easy to collect and record data, these tools only go so far when it comes to ensuring consistency and integrity of a clinical trial. Learn why human intervention is still an important component in decentralized clinical trials when aiming to maximize research efficiency, quality, and value.